不仅仅是一个新的名称:Clostridioides difficile感染管理的最新情况
1Alexander F. Wrynn is an NP at Allegheny Health Network in Pittsburgh, Pa.
The Nurse practitioner
|July 25, 2024
概括
密闭杆菌困难感染 (CDI) 在社区中越来越多,使诊断和治疗复杂化. 本文回顾了护士执业人员对CDI诊断和管理的最新更新.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 临床实践 临床实践
背景情况:
- 困难菌感染 (CDI) 是一个重要的医疗保健挑战.
- 历史上被认为是医院病例,CDI现在显示社区获得病例的增加.
- 诊断的复杂性和不断变化的治疗指南使CDI管理变得复杂.
研究的目的:
- 讨论最近在Clostridioides difficile感染的诊断方面的进展.
- 审查Clostridioides difficile感染的最新管理策略.
- 为执业护士提供关于在实践中应用新的CDI指南的指导.
主要方法:
- 关于Clostridioides difficile感染诊断的当前文献的综述.
- 对Clostridioides difficile感染治疗指南最近变化的分析.
- 综合信息用于临床护理实践中的应用.
主要成果:
- 存在多种CDI诊断测试,其准确性各不相同.
- 最近的指南修订影响了推的Clostridioides difficile感染治疗方法.
- 社区收购的CDI带来了独特的挑战.
结论:
- 准确诊断Clostridioides difficile感染需要了解现有的测试.
- 遵守最新的治疗指南对于有效的CDI管理至关重要.
- 执业护士在管理CDI不断变化的环境中发挥着关键作用.
相关概念视频
01:29Inflammatory Bowel Disease IV: Pharmacological Management
124
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
124
01:17Drugs for Treatment of Diarrhea-Predominant IBS
156
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
156
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
114
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
114
01:21Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
01:21Drugs for Treatment of Constipation-Predominant IBS
152
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
152